NorthRock Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469K | Sell |
5,368
-425
| -7% | -$37.1K | 0.01% | 415 |
|
|
2025
Q1 | $396K | Sell |
5,793
-1,864
| -24% | -$127K | 0.01% | 406 |
|
|
2024
Q4 | $595K | Buy |
7,657
+4,193
| +121% | +$326K | 0.02% | 307 |
|
|
2024
Q3 | $232K | Sell |
3,464
-1,489
| -30% | -$99.8K | 0.01% | 569 |
|
|
2024
Q2 | $562K | Buy |
4,953
+181
| +4% | +$20.5K | 0.02% | 309 |
|
|
2024
Q1 | $662K | Sell |
4,772
-25
| -0.5% | -$3.47K | 0.03% | 280 |
|
|
2023
Q4 | $595K | Buy |
4,797
+1,969
| +70% | +$244K | 0.02% | 275 |
|
|
2023
Q3 | $264K | Sell |
2,828
-375
| -12% | -$35K | 0.03% | 263 |
|
|
2023
Q2 | $412K | Sell |
3,203
-335
| -9% | -$43.1K | 0.05% | 166 |
|
|
2023
Q1 | $411K | Sell |
3,538
-499
| -12% | -$58K | 0.04% | 169 |
|
|
2022
Q4 | $457K | Buy |
4,037
+981
| +32% | +$111K | 0.05% | 170 |
|
|
2022
Q3 | $246K | Buy |
3,056
+162
| +6% | +$13K | 0.03% | 245 |
|
|
2022
Q2 | $216K | Buy |
2,894
+154
| +6% | +$11.5K | 0.02% | 281 |
|
|
2022
Q1 | $350K | Buy |
2,740
+36
| +1% | +$4.6K | 0.03% | 221 |
|
|
2021
Q4 | $363K | Buy |
2,704
+316
| +13% | +$42.4K | 0.03% | 211 |
|
|
2021
Q3 | $326K | Buy |
2,388
+452
| +23% | +$61.7K | 0.03% | 200 |
|
|
2021
Q2 | $207K | Buy |
+1,936
| New | +$207K | 0.02% | 233 |
|
|
2020
Q4 | – | Sell |
-2,244
| Closed | -$231K | – | 230 |
|
|
2020
Q3 | $231K | Buy |
+2,244
| New | +$231K | 0.03% | 194 |
|